Support our Foundation of Myology project
1722 news items
An online survey of genetic information in relatives
On 24/02/2022
As part of the IGP rare project, which emanates from a collective bringing together health professionals, researchers and patient associations, an online survey was launched…
Plasma biomarkers in myositis ossificans
On 24/02/2022
Myositis ossificans or fibrodysplasia ossificans progressive (FOP) is an ultra-rare genetic disease associating progressive ankylosis and malformative bone abnormalities. American researchers have identified several biomarkers…
A meta-analysis confirms the increase of 10 years in life expectancy in DMD
On 24/02/2022
A team of British and Swedish researchers calculated the life expectancy of persons with Duchenne muscular dystrophy (DMD) from individual survival data extracted from survival…
Intranuclear inclusions in oculo-pharyngo-distal myopathy (OPDM)
On 23/02/2022
Oculopharyngodistal myopathy (OPDM) is an ultra-rare autosomal dominant neuromuscular disease in which abnormal CGG-like nucleotide repeats have been identified in three genes (NOTCH2NLC, GIPC1, LRP12).…
Evaluation of Fitbit® connected bracelets in NMD
On 22/02/2022
A study compared two Fitbit® smartwatch models and medical devices (accelerometer, heart monitor, etc.) frequently used in clinical trials, in 110 people with neuromuscular diseases:…
mRNA vaccines in MNM: a satisfactory response despite muscle atrophy
On 21/02/2022
An American team studied the impact of muscle atrophy and corticosteroid therapy on the immune response to messenger RNA (mRNA) vaccines against SARS-CoV-2 in 14…
An inventory of tools used in the assessment of neuromuscular patients
On 21/02/2022
Italian clinicians have compiled data from the literature published between 2000 and 2021 concerning the technological assessment tools used, routinely or during trials, in neuromuscular…
A very rare Kennedy disease genotype in a Norwegian family
On 18/02/2022
Kennedy’s disease is a degenerative disease transmitted in a X-linked recessive mode. The case of two sisters who both inherited two pathological alleles of the…
Irreversible consequences of temporarily stopping ERT in Pompe disease
On 17/02/2022
Due to the Covid-19 epidemic, 31 patients with Pompe disease had to stop their treatment with enzyme replacement therapy (ERT), alglucosidase alfa or Myozyme®, in…
International guidelines to improve assessment in MNMs
On 17/02/2022
Clinical assessment is an essential step not only in the follow-up of patients with neuromuscular pathology but also in the context of trials, whether natural…
ERN EURO-NMD webinar, Feb 24th: Pr Rita Horvath (UK)
On 17/02/2022
Targeted Therapies for Leigh Syndrome: Systematic Review and Steps Towards a “Treatabolome” Thursday February 24th, 2022 – 16:00-17:00 (Paris time) Prof Rita Horvath (University of Cambridge,…
Corticosteroids may improve or stabilize motor function in Fukuyama congenital muscular dystrophy
On 14/02/2022
This is shown by a Japanese prospective study carried out openly in 9 children with an average age of 8.1±2.14 years. One had a moderate…
A new approach to gene therapy for Steinert disease – Interview with Denis Furling
On 10/02/2022
The Denis Furling* team (Paris, France), in collaboration with the Nicolas Sergeant** team (Lille, France), has developed and tested a new approach to gene therapy,…
An ancillary study of the ginivostat trial in Becker myopathy looking for more objective criteria
On 10/02/2022
The primary endpoint for evaluating ginivostat in Becker muscular dystrophy is the change in fibrosis on muscle biopsy after one year of treatment. Based on…
A promising technique to study muscle fibrosis at the cardiac level
On 10/02/2022
French researchers from Nantes have developed a new technique for 3D visualization of muscle fibrosis based on automated image analysis (known as second harmonic generation…
ERN EURO-NMD webinar, Feb 17th: Pr Michelangelo Mancuso (Italy)
On 10/02/2022
Primary mitochondrial myopathies Thursday February 17th, 2022 – 16:00-17:00 (Paris time) Prof Michelangelo Mancuso (University of Pisa & AOUP, Italy) “Mitochondrial Disorders Thematic Month” Webinar…
A first positive assessment of the Japanese myotonic dystrophies registry
On 09/02/2022
Steinert’s disease or myotonic dystrophy type 1 (DM1) is, in Japan as elsewhere, one of the most common neuromuscular diseases, especially in the adult population.…
A cohort of patients with DMD with exon 2 duplication
On 09/02/2022
Duplications of the DMD gene encoding dystrophin are rare and represent a real therapeutic challenge. An American team compiled the clinical and biological data of…
Lower limb exoskeletons: 2 clinical studies starting at the Institute
On 08/02/2022
The rare neuromuscular diseases are characterised, in particular, by a progressive loss of muscle strength. As a result, getting up, sitting down or going up…
M&M’s – Muscle Monday Seminar – 14 February – Cecilia Jimenez-Mallebrera (Spain)
On 08/02/2022
Multiple approaches to investigate congenital muscular dystrophies Monday February 14th, 2022 – 12:00 – 13:00 Cecilia Jimenez-Mallebrera, PhD (Research Coordinator Neuromuscular Unit, Hospital Sant Joan de…
